GSK Completes Acquisition of 35Pharma Inc.
April 16, 2026
April 16, 2026
LONDON, England, April 16 -- GSK (formerly GlaxoSmithKline), a biopharmaceutical company, issued the following news release on April 15, 2026:
* * *
GSK completes acquisition of 35Pharma Inc.
GSK plc (LSE/NYSE: GSK) today announced the completion of its acquisition of 35Pharma Inc., a Canada-based, private, clinical-stage biopharmaceutical company specialising in the development of novel protein-based therapeutics. The acquisition includes HS235, a potentia . . .
* * *
GSK completes acquisition of 35Pharma Inc.
GSK plc (LSE/NYSE: GSK) today announced the completion of its acquisition of 35Pharma Inc., a Canada-based, private, clinical-stage biopharmaceutical company specialising in the development of novel protein-based therapeutics. The acquisition includes HS235, a potentia . . .